# Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies

Study · id `cardio:ct-nct07852689` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07852689](<https://clinicaltrials.gov/study/NCT07852689>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07852689

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07852689. Randomized; no masking; primary purpose treatment. Start 2026-11-16 (actual); primary completion 2028-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07852689, source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)
- Started: 2026-11-16 (actual) (ClinicalTrials.gov record NCT07852689, source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2028-09-30 (anticipated) (ClinicalTrials.gov record NCT07852689, source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)
- Completion: 2029-09-30 (anticipated) (ClinicalTrials.gov record NCT07852689, source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT07852689, source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07852689-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies
- Acronym: FLOW-DCB
- Condition: Coronary Artery Disease
- Condition: Percutaneous Coronary Intervention
- Condition: Drug Coated Balloon
- Condition: Drug Eluting Stents (DES)
- Condition: Fractional Flow Reserve
- Condition: Coronary Physiology
- Intervention (Device): Drug-coated balloon-based intervention
- Intervention (Device): Drug-eluting stent-based intervention
- Lead sponsor: Korea University Guro Hospital
- Lead sponsor class: OTHER
- Collaborator: B. Braun Melsungen AG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Korea University Guro Hospital (`cardio:org-korea-university-guro-hospital`)
- Registry lists this organization as a collaborator: B. Braun Melsungen AG (`cardio:org-b-braun-melsungen-ag`)

## Provenance

Content hash: 4e2a11269f19b8df6471482c28057f63c1e474f4e6fda9e5ef0349a8b1384e43
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
